- Home
- DCTH vs AEF Comparison
DCTH vs AEF Comparison
Compare DCTH & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- AEF
- Stock Information
- Founded
- DCTH 1988
- AEF 1989
- Country
- DCTH United States
- AEF United States
- Employees
- DCTH N/A
- AEF N/A
- Industry
- DCTH Medical/Dental Instruments
- AEF Finance/Investors Services
- Sector
- DCTH Health Care
- AEF Finance
- Exchange
- DCTH Nasdaq
- AEF Nasdaq
- Market Cap
- DCTH 630.4M
- AEF 196.1M
- IPO Year
- DCTH N/A
- AEF N/A
- Fundamental
- Price
- DCTH $12.76
- AEF $5.96
- Analyst Decision
- DCTH Strong Buy
- AEF
- Analyst Count
- DCTH 4
- AEF 0
- Target Price
- DCTH $24.00
- AEF N/A
- AVG Volume (30 Days)
- DCTH 748.0K
- AEF 92.5K
- Earning Date
- DCTH 08-04-2025
- AEF 01-01-0001
- Dividend Yield
- DCTH N/A
- AEF 7.13%
- EPS Growth
- DCTH N/A
- AEF N/A
- EPS
- DCTH N/A
- AEF 0.57
- Revenue
- DCTH $53,850,000.00
- AEF N/A
- Revenue This Year
- DCTH $155.42
- AEF N/A
- Revenue Next Year
- DCTH $37.93
- AEF N/A
- P/E Ratio
- DCTH N/A
- AEF $8.86
- Revenue Growth
- DCTH 1068.87
- AEF N/A
- 52 Week Low
- DCTH $7.17
- AEF $4.40
- 52 Week High
- DCTH $18.23
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- DCTH 32.99
- AEF 68.17
- Support Level
- DCTH $13.30
- AEF $5.51
- Resistance Level
- DCTH $14.15
- AEF $5.97
- Average True Range (ATR)
- DCTH 0.66
- AEF 0.08
- MACD
- DCTH -0.27
- AEF 0.01
- Stochastic Oscillator
- DCTH 2.91
- AEF 91.30
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.